Credo (CRDO) stock jumps 6% after-hours after insider filings; Needham conference is next focus
8 January 2026
1 min read

Credo (CRDO) stock jumps 6% after-hours after insider filings; Needham conference is next focus

New York, January 7, 2026, 18:57 (EST) — After-hours

  • Credo Technology shares rose about 6% in late trading, after a wide swing in the regular session.
  • Form 4 filings showed several executives had shares withheld to cover taxes tied to vested stock awards.
  • The company is due to present at Needham’s Growth Conference in New York on Jan. 14.

Credo Technology Group Holding Ltd shares rose about 6% to $141 in after-hours trading on Wednesday, after swinging between $124.85 and $143.14 in the regular session. The Nasdaq-listed stock is about 6% below its 52-week high of $150.76.

The move matters because Credo sits in the middle of the AI data-center buildout trade — a part of semiconductors where sentiment can turn on small scraps of information. When a high-beta stock like this whipsaws in a day, investors usually go looking for a trigger, even if it is just positioning.

One near-term focus is an investor conference slot that could turn into a mini-checkpoint on demand. Credo said CEO Bill Brennan and CFO Dan Fleming will present at the 28th Annual Needham Growth Conference in New York City on Jan. 14 at 9:30 a.m. ET, with a live webcast on its investor relations site.

Trading was busy. About 9.8 million shares changed hands during mid-day trading, around 27% above average volume, MarketBeat data showed. 1

A batch of insider-trading filings filed on Jan. 6 also landed in front of traders. Form 4 disclosures showed Brennan, Fleming and Chief Operating Officer Yat Tung Lam had small blocks of ordinary shares withheld on Jan. 2 and Jan. 5 at prices around $140–$143; the filings showed they still held sizable stakes after the transactions.

The filings described the transactions as share withholding to cover tax obligations tied to vested restricted stock units, a common form of stock compensation that converts to shares when it vests. That is different from an open-market sale, but it can still show up on screens that track insider activity.

Technically, Wednesday left two obvious levels on the chart. The intraday low near $125 is the closest support traders will point to, while the 52-week high just above $150 is the hurdle on the upside.

The risk is that investors read too much into routine filings or conference appearances. With the stock still sensitive to changes in AI-related spending and data-center build plans, any soft tone on orders, margins or product ramps can bring the selling back fast.

Next up is the Jan. 14 Needham presentation, where investors will listen for updates on demand, customer deployments and any change in the company’s near-term outlook.

Stock Market Today

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

7 February 2026
Home Depot shares rose 0.7% to $385.15 Friday, trading between $379.10 and $386.37. Investors await a delayed U.S. jobs report Wednesday and CPI data Friday, both postponed by a brief government shutdown. Home Depot reports fourth-quarter earnings Feb. 24. The Dow closed above 50,000 for the first time.
JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

7 February 2026
JPMorgan shares rose 3.95% to $322.40 Friday, outpacing other major banks as U.S. stocks rallied and the Dow closed above 50,000 for the first time. The bank recently completed a $3 billion subordinated notes offering. Investors are watching for delayed U.S. jobs data and inflation figures next week, ahead of JPMorgan’s Feb. 23 company update.
AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

7 February 2026
AbbVie shares rose 2% to $223.43 Friday, capping a volatile week marked by earnings and drug sales scrutiny. Moody’s upgraded AbbVie’s credit rating to A2, citing strong performance in immunology and neuroscience. Investors remain focused on Skyrizi and Rinvoq growth amid rising competition and recent regulatory filings. Trading volume stayed below average, with the stock still 9% off its 52-week high.
SK hynix stock price slips into Monday after S&P upgrade, tech selloff

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

7 February 2026
SK hynix shares closed at 839,000 won, down 0.36% Friday and 8% for the week, as tech stocks retreated across Asia. S&P Global Ratings upgraded the chipmaker to “BBB+” with a positive outlook, citing strong HBM sales. The KOSPI fell 1.4% Friday, ending a six-week winning streak. Traders await Monday’s Seoul open for signs of further tech weakness.
Dell stock slides 3% after CES XPS comeback as memory costs loom
Previous Story

Dell stock slides 3% after CES XPS comeback as memory costs loom

KLA stock slides after-hours as chip gear names cool off; India R&D expansion in focus
Next Story

KLA stock slides after-hours as chip gear names cool off; India R&D expansion in focus

Go toTop